EROSHA C JAYAWARDENA

Allopathic & Osteopathic Physicians|Hospitalist ATLANTA, GA NPI 1740410596

General Payments — all program years on this page

$2,214.30

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 120
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $563.45 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $563.4521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $340.7720
2019 $405.3127
2020 $82.945
2021 $262.1616
2022 $214.0613
2023 $345.6118
2024 $563.4521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077987298 Janssen Pharmaceuticals, Inc $35.97 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077987334 Janssen Pharmaceuticals, Inc $21.79 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077987986 Janssen Pharmaceuticals, Inc $32.30 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077988018 Janssen Pharmaceuticals, Inc $116.37 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087115566 Novartis Pharmaceuticals Corporation $21.71 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096611392 Novo Nordisk Inc $22.15 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097144599 Novo Nordisk Inc $22.48 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097293006 Novo Nordisk Inc $20.85 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097584926 Novo Nordisk Inc $18.01 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103990989 ABBVIE INC. $19.29 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103990991 ABBVIE INC. $24.95 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103990993 ABBVIE INC. $22.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104650245 AstraZeneca Pharmaceuticals LP $24.72 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118135535 Boehringer Ingelheim Pharmaceuticals, Inc. $14.04 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118135537 Boehringer Ingelheim Pharmaceuticals, Inc. $17.23 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127029911 Kyowa Kirin, Inc. $21.00 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141568176 Merck Sharp & Dohme LLC $22.83 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144594258 Xeris Pharmaceuticals, Inc. $23.64 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145087604 Mallinckrodt Hospital Products Inc. $18.22 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145087608 Mallinckrodt Hospital Products Inc. $24.29 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153657609 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.71 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.